We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$1.75B
AUM Growth
+$122M
Cap. Flow
+$153M
Cap. Flow %
8.76%
Top 10 Hldgs %
16.51%
Holding
165
New
17
Increased
24
Reduced
99
Closed
14

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$218M
2
AGN
Allergan plc
AGN
+$15.6M
3
TRN icon
Trinity Industries
TRN
+$12.6M
4
SBNY
Signature Bank
SBNY
+$11M
5
LRCX icon
Lam Research
LRCX
+$10.2M

Top Sells

Rank Stock Value
1
OC icon
Owens Corning
OC
+$12.2M
2
THC icon
Tenet Healthcare
THC
+$8.44M
3
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$7.76M
4
CSCO icon
Cisco
CSCO
+$4.65M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.36M

Sector Composition

Rank Sector Weight
1 Financials 16.59%
2 Technology 14.06%
3 Healthcare 13.9%
4 Industrials 11.34%
5 Consumer Discretionary 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRI icon
26
Capri Holdings
CPRI
$1.88B
$20.2M 1.15%
248,240
-10,810
-4% -$853K
PFE icon
27
Pfizer
PFE
$143B
$19.8M 1.14%
682,490
-26,380
-4% -$768K
MON
28
DELISTED
Monsanto Co
MON
$19.6M 1.12%
168,490
+675
+0.4% +$73.7K
INVN
29
DELISTED
Invensense Inc
INVN
$19.6M 1.12%
942,839
-1,771
-0.2% -$31.7K
PII icon
30
Polaris
PII
$4.02B
$19.3M 1.1%
132,232
+432
+0.3% +$57.8K
JNJ icon
31
Johnson & Johnson
JNJ
$613B
$19.2M 1.1%
209,928
-6,097
-3% -$562K
LKQ icon
32
LKQ Corp
LKQ
$5.91B
$19.1M 1.09%
579,510
-41,895
-7% -$1.37M
AZPN
33
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$18.9M 1.08%
452,628
-11,062
-2% -$462K
APH icon
34
Amphenol
APH
$201B
$18.8M 1.07%
1,683,536
-27,600
-2% -$285K
NXPI icon
35
NXP Semiconductors
NXPI
$56.5B
$18.6M 1.06%
404,382
-12,118
-3% -$499K
WFC icon
36
Wells Fargo
WFC
$266B
$18.3M 1.05%
403,528
-41,311
-9% -$1.78M
DHR icon
37
Danaher
DHR
$139B
$18.2M 1.04%
351,174
+9,678
+3% +$476K
MET icon
38
MetLife
MET
$62B
$17.8M 1.02%
370,792
-398
-0.1% -$17.8K
FISV
39
Fiserv Inc
FISV
$29B
$17.8M 1.02%
603,030
-28,170
-4% -$760K
MRK icon
40
Merck
MRK
$316B
$17.8M 1.02%
371,724
-3,325
-0.9% -$152K
PAYX icon
41
Paychex
PAYX
$41.9B
$17.7M 1.01%
388,635
-19,905
-5% -$850K
CB
42
DELISTED
CHUBB CORPORATION
CB
$17.6M 1.01%
182,621
-12,182
-6% -$1.14M
GS icon
43
Goldman Sachs
GS
$303B
$17.6M 1.01%
99,406
-9,252
-9% -$1.53M
ELV icon
44
Elevance Health
ELV
$83B
$17.5M 1%
189,850
-1,445
-0.8% -$128K
USB icon
45
US Bancorp
USB
$99.6B
$17.5M 1%
432,177
-36,078
-8% -$1.38M
OII icon
46
Oceaneering
OII
$4.85B
$17.4M 0.99%
220,330
-10,925
-5% -$887K
TRV icon
47
Travelers Companies
TRV
$78B
$17.4M 0.99%
191,688
-19,433
-9% -$1.7M
QCOM icon
48
Qualcomm
QCOM
$159B
$17.2M 0.98%
231,340
-11,790
-5% -$832K
AGN
49
DELISTED
Allergan plc
AGN
$16.8M 0.96%
+99,951
New +$15.6M
CSX icon
50
CSX Corp
CSX
$92.3B
$16.8M 0.96%
1,749,687
+20,700
+1% +$185K
1
2
3 4 5

Similar funds

CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Braun Stacey Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Braun Stacey Associates held 165 positions worth $1.75B, up 7.5% from $1.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Braun Stacey Associates deployed $153M of net new capital in Q4 2013, opening 17 new positions and adding to 24 existing holdings. Its largest new stake was Allergan plc: 99,951 shares worth $16.8M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was CATAMARAN CORP COM STK (CDA), an estimated $7.76M trimmed.

  • Braun Stacey Associates's largest Q4 2013 buy was Allergan plc: 99,951 shares worth $16.8M.
  • Braun Stacey Associates added most to Mastercard in Q4 2013, an estimated $218M increase.
  • Braun Stacey Associates's biggest Q4 2013 reduction was CATAMARAN CORP COM STK (CDA), cutting an estimated $7.76M.
  • Braun Stacey Associates fully exited Owens Corning in Q4 2013, selling an estimated $12.2M.
  • Braun Stacey Associates's ten largest holdings make up 17% of its $1.75B portfolio in Q4 2013.
  • Braun Stacey Associates opened 17 new positions and closed 14 in Q4 2013.
  • Braun Stacey Associates's portfolio value rose 7.5% quarter-over-quarter to $1.75B.

Based on Braun Stacey Associates's 13F filing for Q4 2013, filed 20 Feb 2014.